8-K
0001828318false00018283182022-06-152022-06-15

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 15, 2022

 

 

Enovix Corporation

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39753

85-3174357

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3501 W. Warren Avenue

 

Fremont, California

 

94538

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (510) 695-2350

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

ENVX

 

The NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 15, 2022, Enovix Corporation (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 29, 2022. The following is a brief description of each matter voted on at the Annual Meeting, including the number of votes cast with respect to each matter and, if applicable, the number of abstentions and broker non-votes with respect to each matter.

Proposal 1 – Election of Directors

Stockholders approved the election of each of the Company’s seven (7) directors to serve for a one-year term until the Company’s 2023 Annual Meeting of Stockholders. The results of the voting were as follows:

 

Nominee

 

For

 

 

Withheld

 

 

Broker Non-Votes

 

Harrold J. Rust

 

 

82,241,834

 

 

 

480,229

 

 

 

33,586,250

 

Thurman J. “T.J.” Rodgers

 

 

82,291,123

 

 

 

430,940

 

 

 

33,586,250

 

Betsy Atkins

 

 

67,098,038

 

 

 

15,624,025

 

 

 

33,586,250

 

Pegah Ebrahimi

 

 

81,806,081

 

 

 

915,982

 

 

 

33,586,250

 

Emmanuel T. Hernandez

 

 

82,262,142

 

 

 

459,921

 

 

 

33,586,250

 

John D. McCranie

 

 

82,254,777

 

 

 

467,286

 

 

 

33,586,250

 

Gregory Reichow

 

 

82,197,805

 

 

 

524,258

 

 

 

33,586,250

 


Proposal 2 – Ratification of Appointment of Independent Registered Accounting Firm

Stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 1, 2023. The results of the voting were as follows:

 

For

 

 

Against

 

 

Abstain

 

 

Broker Non-Votes

 

 

116,162,806

 

 

 

119,732

 

 

 

25,775

 

 

 

 

 

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Enovix Corporation

 

 

 

 

Date:

June 17, 2022

By:

/s/ Steffen Pietzke

 

 

 

Steffen Pietzke
Chief Financial Officer